Single‐Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis
Advanced Materials · 2023-03 · 35 (9)
DOI: 10.1002/adma.202208512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023-01. Verfasst von Yang Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Electrons, Neoplasms. Die Arbeit wurde bisher 170-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Foundation of National Facility for Translational Medicine.
Abstract (Originalsprache)
Nanozyme catalytic therapy triggered by tumor‐specific endogenous stimuli is an emerging tumor therapy that attracts wide attention. However, the current therapeutic efficacy of nanozyme catalytic therapy is severely limited by the catalytic efficiency of nanozymes and the concentration of endogenous reaction substrates. Herein, a novel and efficient IrN 5 single‐atom (IrN 5 SA) nanozyme is developed with multiple enzyme‐like catalytic activities. Due to the synergistic effect of central Ir single‐atom and axial N coordination, IrN 5 SA exhibits better enzymatic catalytic performance than IrN 4 SA. At tumor sites, IrN 5 SA can generate a large amount of reactive oxygen species (ROS) through oxidase (OXD)‐like and peroxidase (POD)‐like catalytic activities. Moreover, IrN 5 SA can also generate O 2 and hydrogen peroxide (H 2 O 2 ) through catalase (CAT)‐like and nicotinamide adenine dinucleotide (NADH) oxidase (NOX)‐like catalytic activities, realizing the efficient nanozyme catalytic therapy in a substrate‐cycle manner. Additionally, IrN 5 SA can effectively break the intracellular NADH/NAD + cycle balance by mimicking NOX, and then cooperate with fatty acid synthase cerulenin (Cer) to interfere with the energy metabolism homeostasis of tumor cells. Consequently, the designed IrN 5 SA/Cer nanoagent can disrupt redox and metabolic homeostasis in the tumor region through an enzyme‐mimicking cascade reaction, effectively overcoming the shortcomings of current nanozyme catalytic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.
- School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, 637371, Singapore.
ORCID-Profile: Yang Yang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Foundation of National Facility for Translational Medicine
Zitieren
APA
Liu, Y., Wang, B., Zhu, J., Xu, X., Zhou, B., & Yang, Y. (2023). Single‐Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis. Advanced Materials, 35(9). https://doi.org/10.1002/adma.202208512
Vancouver
Liu Y, Wang B, Zhu J, Xu X, Zhou B, Yang Y. Single‐Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis. Advanced Materials. 2023;35(9). doi:10.1002/adma.202208512
BibTeX
@article{Liu2023,
author = {Liu, Yang and Wang, Bo and Zhu, Junjie and Xu, Xinnan and Zhou, Bin and Yang, Yang},
title = {Single‐Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {9},
doi = {10.1002/adma.202208512}
}
EUVIMED